Vanderbilt Ingram Cancer Center

Research conducted by medical students recognized at events

Vanderbilt-Ingram Cancer Center, Meharry Medical College and Tennessee State University Cancer Partnership recently hosted the 2018 annual retreat and poster contest, “Health Disparities in Cancer Immunology & Immune Therapy.”

Cancer immunotherapies expert Allison set for Discovery Lecture

James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.

New members named to VUMC advisory boards, councils

Twenty-three volunteer leaders have been named to fill positions on three of Vanderbilt University Medical Center’s (VUMC) advisory boards and councils.

African American woman in pink crossing her hands over her breast

Study seeks to boost breast tumor immune response

Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer.

Sberna named VICC Strategy and Analytics director

Theresa Sberna, MPH, has been named director of Strategy and Analytics for Vanderbilt-Ingram Cancer Center (VICC). Sberna, who previously served as associate director, has been with the Cancer Center for five years.

four african american women posing for a photo outside. some are overweight.

Rising obesity rates in South leading to rapid increase in diabetes

Rising obesity rates in several Southern states are leading to a rapid increase in new cases of diabetes among both black and white adults. A new study helmed by investigators at the University of Texas Health Science Center and Vanderbilt University Medical Center (VUMC) found the risk of diabetes is double for black patients.

1 26 27 28 29 30 58